volume 20, issue 8, P577-580 1994
DOI: 10.1007/bf01705725
View full text
|
Sign up to set email alerts
|
Share

Abstract: The results suggest that the administration of AT III concentrates to critical patients with acquired low levels, but without manifest DIC, may not be justified; although further studies on a larger population are required to establish definite conclusions.